(Q36115468)

English

High-dose chemotherapy followed by reinfusion of selected CD34+ peripheral blood cells in patients with poor-prognosis breast cancer: a randomized multicentre study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

High-dose chemotherapy followed by reinfusion of selected CD34+ peripheral blood cells in patients with poor-prognosis breast cancer: a randomized multicentre study (English)

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

multicenter clinical trial

0 references

1 reference

based on heuristic

inferred from title

author name string

Chabannon C

1

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Cornetta K

2

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Lotz JP

3

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Rosenfeld C

4

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Shlomchik M

5

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Yanovitch S

6

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Marolleau JP

7

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Sledge G

8

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Novakovitch G

9

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Srour EF

10

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Burtness B

11

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Camerlo J

12

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Gravis G

13

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Lee-Fischer J

14

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Faucher C

15

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Chabbert I

16

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Krause D

17

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Maraninchi D

18

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Mills B

19

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Kunkel L

20

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Oldham F

21

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Blaise D

22

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Viens P

23

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

language of work or name

0 references

publication date

1 October 1998

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

British Journal of Cancer

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

78

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

7

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

913-921

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

A prospective randomized trial of buffy coat versus CD34-selected autologous bone marrow support in high-risk breast cancer patients receiving high-dose chemotherapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063121

2 October 2017

The biology and clinical uses of blood stem cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063121

2 October 2017

Peripheral blood stem cell and bone marrow transplantation for solid tumors and lymphomas: hematologic recovery and costs. A randomized, controlled trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063121

2 October 2017

Selection and expansion of peripheral blood CD34+ cells in autologous stem cell transplantation for breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063121

2 October 2017

Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of multiple myeloma patients: positive selection and transplantation of enriched CD34+ cells to remove circulating tumor cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063121

2 October 2017

High-dose chemotherapy with hematopoietic rescue as primary treatment for metastatic breast cancer: a randomized trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063121

2 October 2017

Dose-response effect of adjuvant chemotherapy in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063121

2 October 2017

Bone marrow autotransplantation for solid tumors--prospects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063121

2 October 2017

Treatment of estrogen receptor-negative or hormonally refractory breast cancer with double high-dose chemotherapy intensification and bone marrow support

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063121

2 October 2017

CD34+ marrow cells, devoid of T and B lymphocytes, reconstitute stable lymphopoiesis and myelopoiesis in lethally irradiated allogeneic baboons

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063121

2 October 2017

Molecular cloning of a cDNA encoding CD34, a sialomucin of human hematopoietic stem cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063121

2 October 2017

The risk of tumor cell contamination in peripheral blood stem cell collections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063121

2 October 2017

Defining a Therapeutic Dose of Peripheral Blood Stem Cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063121

2 October 2017

Effect of CD34+ selection and various schedules of stem cell reinfusion and granulocyte colony-stimulating factor priming on hematopoietic recovery after high-dose chemotherapy for breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063121

2 July 2018

Binding of L-selectin to the vascular sialomucin CD34.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063121

2 July 2018

Bone marrow reconstitution after high-dose chemotherapy and autologous peripheral blood progenitor cell transplantation: effect of graft size

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063121

2 July 2018

A randomized trial of two dose levels of cyclophosphamide, methotrexate, and fluorouracil chemotherapy for patients with metastatic breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063121

2 July 2018

High-dose chemotherapy with reinfusion of purged autologous bone marrow following dose-intense induction as initial therapy for metastatic breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063121

2 July 2018

Gene-marking to trace origin of relapse after autologous bone-marrow transplantation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063121

23 September 2018

Genetic marking shows that Ph+ cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063121

23 September 2018

Immunomagnetic selection of CD34+ peripheral blood stem cells for autografting in patients with breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/9764583

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

4-Hydroperoxycyclophosphamide purging of breast cancer from the mononuclear cell fraction of bone marrow in patients receiving high-dose chemotherapy and autologous marrow support: a phase I trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/9764583

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Engraftment after infusion of CD34+ marrow cells in patients with breast cancer or neuroblastoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/9764583

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunomagnetic purging of breast cancer from bone marrow for autologous transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/9764583

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

"Classical" CMF versus a 3-weekly intravenous CMF schedule in postmenopausal patients with advanced breast cancer. An EORTC Breast Cancer Co-operative Group Phase III Trial (10808)

1 reference

https://pubmed.ncbi.nlm.nih.gov/9764583

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bone marrow versus peripheral blood progenitor cells CD34 selection in patients with non-Hodgkin's lymphomas: different levels of tumor cell reduction. Implications for autografting

1 reference

https://pubmed.ncbi.nlm.nih.gov/9764583

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase II study of high-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/9764583

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/9764583

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques

1 reference

https://pubmed.ncbi.nlm.nih.gov/9764583

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment

1 reference

https://pubmed.ncbi.nlm.nih.gov/9764583

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/9764583

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/9764583

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Positively selected autologous blood CD34+ cells and unseparated peripheral blood progenitor cells mediate identical hematopoietic engraftment after high-dose VP16, ifosfamide, carboplatin, and epirubicin

1 reference

https://pubmed.ncbi.nlm.nih.gov/9764583

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte colony stimulating factor (rhG-CSF): an analysis of factors correlating with the tempo of engraftment after transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/9764583

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of G-CSF-primed peripheral blood progenitor cells and bone marrow auto transplantation: clinical assessment and cost-effectiveness

1 reference

https://pubmed.ncbi.nlm.nih.gov/9764583

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patient condition affects the collection of peripheral blood progenitors after priming with recombinant granulocyte colony-stimulating factor

1 reference

https://pubmed.ncbi.nlm.nih.gov/9764583

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/9764583

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/9764583

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

G-CSF alone mobilizes sufficient peripheral blood CD34+ cells for positive selection in newly diagnosed patients with myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/9764583

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transplantation of allogeneic CD34+ blood cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/9764583

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hematopoietic precursor cell transplants in Europe: activity in 1994. Report from the European Group for Blood and Marrow Transplantation (EBMT)

1 reference

https://pubmed.ncbi.nlm.nih.gov/9764583

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical significance of bone marrow metastases as detected using the polymerase chain reaction in patients with breast cancer undergoing high-dose chemotherapy and autologous bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/9764583

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Highly purified CD34-positive cells reconstitute hematopoiesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9764583

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transplantation of allogeneic CD34+ peripheral blood stem cells in patients with advanced hematologic malignancy

1 reference

https://pubmed.ncbi.nlm.nih.gov/9764583

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monitoring of tumor cell purging after highly efficient immunomagnetic selection of CD34 cells from leukapheresis products in breast cancer patients: comparison of immunocytochemical tumor cell staining and reverse transcriptase-polymerase chain rea

1 reference

https://pubmed.ncbi.nlm.nih.gov/9764583

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autologous transplantation of blood stem cells mobilized with filgrastim alone in 93 patients with malignancies: the number of CD34+ cells reinfused is the only factor predicting both granulocyte and platelet recovery

1 reference

https://pubmed.ncbi.nlm.nih.gov/9764583

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peripheral blood stem cell CD34+ autologous transplant in relapsed follicular lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/9764583

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Engraftment and molecular monitoring of CD34+ peripheral-blood stem-cell transplants for follicular lymphoma: a pilot study

1 reference

https://pubmed.ncbi.nlm.nih.gov/9764583

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/BJC.1998.601

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36115468&oldid=2198221461"